Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fondazione Epatocentro Ticino is a specialized Swiss medical and research foundation dedicated to the diagnosis, treatment, and study of liver diseases. Based in Lugano, the center operates as a hub of excellence for hepatology, providing advanced clinical care for conditions such as viral hepatitis, metabolic liver disease, and liver cancer. The foundation is heavily involved in clinical research, serving as a key site for international Phase I-IV clinical trials investigating novel therapeutic agents. By integrating clinical practice with academic research, the organization aims to improve patient outcomes and contribute to global hepatological advancements. It also plays a significant role in public health initiatives, including the Swiss Hepatitis Strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fondazione Epatocentro Ticino.